Русский
Библиографические ссылки статьи: “Иммунная тромбоцитопения: что может предложить системная биология и системная физиология?”
  1. International consensus report on the investigation and management of primary immune thrombocytopenia

    D. Provan, R. Stasi, A. Newland, V. Blanchette, P. Bolton-Maggs, J. Bussel, B. Chong, D. Cines, T. Gernsheimer, B. Godeau, J. Grainger, I. Greer, B. Hunt, P. Imbach, G. Lyons, R. McMillan, F. Rodeghiero, M. Sanz, M. Tarantino, S. Watson, J. Young, D. Kuter

    Blood. 2010, 115, 168-186

  2. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

    C. Neunert, W. Lim, M. Crowther, A. Cohen, L. Solberg, M. Crowther

    Blood. 2011, 117, 4190-4207

  3. Chronic Immune Thrombocytopenia in Adults: Epidemiology and Clinical Presentation

    P. Fogarty

    Hematology/Oncology Clinics of North America. 2009, 23, 1213-1221

  4. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database

    M. Yong, W. Schoonen, L. Li, G. Kanas, J. Coalson, F. Mowat, J. Fryzek, J. Kaye

    British Journal of Haematology. 2010, 149, 855-864

  5. Platelet Autoantibodies in Immune Thrombocytopenic Purpura

    D. Beardsley, M.D., Ph.D, M. Ertem, M.D

    Transfusion Science. 1998, 19, 237-244

  6. Specificity of autoantibodies in autoimmune thrombocytopenia

    van Leeuwen EF, van der Ven JT, Engelfriet CP, von dem Borne AE.

    Blood. 1982, 59, 23-26

  7. SIMILARITIES BETWEEN KNOWN ANTIPLATELET ANTIBODIES AND THE FACTOR RESPONSIBLE FOR THROMBOCYTOPENIA IN IDIOPATHIC PURPURA. PHYSIOLOGIC, SEROLOGIC AND ISOTOPIC STUDIES

    N. Shulman, V. Marder, R. Weinrach

    Annals of the New York Academy of Sciences. 2006, 124, 499-542

  8. Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry

    D. Arnold, I. Nazy, R. Clare, A. Jaffer, B. Aubie, N. Li, J. Kelton

    Blood Advances. 2017, 1, 2414-2420

  9. Pathobiology of Secondary Immune Thrombocytopenia

    D. Cines, H. Liebman, R. Stasi

    Seminars in Hematology. 2009, 46, S2-S14

  10. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis

    H. Zhao, S. Li, R. Yang

    Platelets. 2010, 21, 380-385

  11. Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?

    R. Tomasello, G. Giordano, F. Romano, F. Vaccarino, S. Siragusa, A. Lucchesi, M. Napolitano

    Biomedicines. 2021, 9, 1170

  12. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C–related immunologic thrombocytopenia

    W. Zhang, M. Nardi, W. Borkowsky, Z. Li, S. Karpatkin

    Blood. 2009, 113, 4086-4093

  13. Role of molecular mimicry to HIV-1 peptides in HIV-1–related immunologic thrombocytopenia

    Z. Li, M. Nardi, S. Karpatkin

    Blood. 2005, 106, 572-576

  14. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori -associated chronic idiopathic thrombocytopenic purpura

    T. Takahashi, T. Yujiri, K. Shinohara, Y. Inoue, Y. Sato, Y. Fujii, M. Okubo, Y. Zaitsu, K. Ariyoshi, Y. Nakamura, R. Nawata, Y. Oka, M. Shirai, Y. Tanizawa

    British Journal of Haematology. 2004, 124, 91-96

  15. Immune thrombocytopenia in lymphoproliferative diseases

    B. Kaden, W. Rosse, T. Hauch

    Blood. 1979, 53, 545-551

  16. Drug-Induced Immune Thrombocytopenia

    R. Aster, D. Bougie

    New England Journal of Medicine. 2007, 357, 580-587

  17. Chronic Idiopathic Thrombocytopenic Purpura

    J. George, M. El-Harake, G. Raskob

    New England Journal of Medicine. 1994, 331, 1207-1211

  18. Thrombopoietin receptor agonists for the treatment of severe persistent and chronic immune trombocytopenia in children: clinical data of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

    E. Suntsova, A. Maschan, O. Mironenko, D. Baydildina, I. Kalinina, M. Korsantya, N. Kotskaya, Z. Kuzminova, G. Ovsyannikova, U. Petrova, A. Pshonkin, M. Sadovskaya, T. Salimova, N. Trubina, D. Fedorova, G. Novichkova

    Pediatric Hematology/Oncology and Immunopathology. , 20, 12-25

  19. First-Line Therapy for Immune Thrombocytopenia

    S. Mithoowani, D. Arnold

    Hämostaseologie. 2019, 39, 259-265

  20. Corticosteroids: The drugs to beat

    P. Barnes

    European Journal of Pharmacology. 2006, 533, 2-14

  21. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin

    D. Leontyev, Y. Katsman, X. Ma, S. Miescher, F. Käsermann, D. Branch

    Transfusion. 2012, 52, 1799-1805

  22. Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia

    S. Wang, K. Yang, C. Lin, A. Huang, C. Hsiao, M. Lin, Y. Tsai

    Pediatric Blood & Cancer. 2020, 67,

  23. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults

    F. Borst, J. Keuning, H. van Hulsteijn, H. Sinnige, G. Vreugdenhil

    Annals of Hematology. 2004, 83, 764-768

  24. Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura

    M. Hou, J. Peng, Y. Shi, C. Zhang, P. Qin, C. Zhao, X. Ji, X. Wang, M. Zhang

    European Journal of Haematology. 2003, 70, 353-357

  25. Efficacy of cyclosporine as a single agent therapy in chronic idiopathic thrombocytopenic purpura

    D. Choudhary, R. Naithani, M. Mahapatra, R. Kumar, P. Mishra, R. Saxena

    Haematologica. 2008, 93, e61-e62

  26. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

    M. Khellaf, A. Charles-Nelson, O. Fain, L. Terriou, J. Viallard, S. Cheze, J. Graveleau, B. Slama, S. Audia, M. Ebbo, G. Le Guenno, M. Cliquennois, G. Salles, C. Bonmati, F. Teillet, L. Galicier, A. Hot, O. Lambotte, F. Lefrère, S. Sacko, D. Kengue, P. Bierling, F. Roudot-Thoraval, M. Michel, B. Godeau

    Blood. 2014, 124, 3228-3236

  27. Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

    M. Lozano, M. Mingot-Castellano, M. Perera, I. Jarque, R. Campos-Alvarez, T. González-López, G. Carreño-Tarragona, N. Bermejo, M. Lopez-Fernandez, A. de Andrés, D. Valcarcel, L. Casado-Montero, M. Alvarez-Roman, M. Orts, S. Novelli, N. Revilla, J. González-Porras, E. Bolaños, M. Rodríguez-López, E. Orna-Montero, V. Vicente

    Scientific Reports. 2019, 9, 16680

  28. Laparoscopic splenectomy for ITP

    R. Friedman, M. Fallas, B. Carroll, J. Hiatt, E. Phillips

    Surgical Endoscopy. 1996, 10, 991-995

  29. Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications?

    F. Rodeghiero, M. Ruggeri

    British Journal of Haematology. 2012, 158, 16-29

  30. Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis

    E. Bourgeois, M. Caulier, C. Delarozee, M. Brouillard, F. Bauters, P. Fenaux

    British Journal of Haematology. 2003, 120, 1079-1088

  31. Anti‐platelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications

    D. Schmidt, K. Heitink‐Polle, L. Porcelijn, C. Schoot, G. Vidarsson, M. Bruin, M. Haas

    Journal of Thrombosis and Haemostasis. 2020, 18, 1210-1220

  32. Clinical Role of Antiplatelet Antibody Assays

    R. McMillan

    Seminars in Thrombosis and Hemostasis. 1995, 21, 37-45

  33. Mechanisms of platelet recovery in ITP associated with therapy

    S. Pang, A. Lazarus

    Annals of Hematology. 2010, 89, 31-35

  34. Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis

    K. Heitink-Pollé, J. Nijsten, C. Boonacker, M. de Haas, M. Bruin

    Blood. 2014, 124, 3295-3307

  35. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group

    T. Kühne, G. Buchanan, S. Zimmerman, L. Michaels, R. Kohan, W. Berchtold, P. Imbach

    The Journal of Pediatrics. 2003, 143, 605-608

  36. ITP following vaccination

    P. David, Y. Shoenfeld

    International Journal of Infectious Diseases. 2020, 99, 243-244

  37. MMR vaccine and idiopathic thrombocytopaenic purpura

    C. Black, J. Kaye, H. Jick

    British Journal of Clinical Pharmacology. 2003, 55, 107-111

  38. Spectrum of Ig Classes, Specificities, and Titers of Serum Antiglycoproteins in Chronic Idiopathic Thrombocytopenic Purpura

    He R, Reid DM, Jones C, Shulman NR

    Blood. 1994, 83 (4), 1024-32

  39. Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins IIb/IIIa and Ib/IX in patients with thrombocytopenia

    V. Kiefel, E. Freitag, H. Kroll, S. Santoso, C. Mueller-Eckhardt

    Annals of Hematology. 1996, 72, 280-285

  40. FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia

    P. Norris, G. Segel, W. Burack, U. Sachs, S. Lissenberg-Thunnissen, G. Vidarsson, B. Bayat, C. Cserti-Gazdewich, J. Callum, Y. Lin, D. Branch, R. Kapur, J. Semple, A. Lazarus

    Haematologica. 2020, 106, 250-254

  41. Immune Regulatory Function of B Cells

    C. Mauri, A. Bosma

    Annual Review of Immunology. 2012, 30, 221-241

  42. Reference values for B cell subpopulations from infancy to adulthood

    H. Morbach, E. Eichhorn, J. Liese, H. Girschick

    Clinical and Experimental Immunology. 2010, 162, 271-279

  43. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling

    S. Herzog, M. Reth, H. Jumaa

    Nature Reviews Immunology. 2009, 9, 195-205

  44. Regulation of plasma-cell development

    M. Shapiro-Shelef, K. Calame

    Nature Reviews Immunology. 2005, 5, 230-242

  45. Receptor editing: an approach by autoreactive B cells to escape tolerance.

    D. Gay, T. Saunders, S. Camper, M. Weigert

    Journal of Experimental Medicine. 1993, 177, 999-1008

  46. The imbalance between regulatory memory B cells reveals possible pathogenesis involvement in pediatric immune thrombocytopenia

    J. Fang, L. Lin, D. Lin, R. Zhang, X. Liu, D. Wang, C. Duan, X. Lin

    Hematology. 2019, 24, 473-479

  47. Memory B-cell persistence is independent of persisting immunizing antigen

    M. Maruyama, K. Lam, K. Rajewsky

    Nature. 2000, 407, 636-642

  48. The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia

    X. Zhu, Y. Shi, J. Peng, C. Guo, N. Shan, P. Qin, X. Ji, M. Hou

    Blood. 2009, 114, 5362-5367

  49. Flow cytometric immunobead assay for quantitative detection of platelet autoantibodies in immune thrombocytopenia patients

    J. Zhai, M. Ding, T. Yang, B. Zuo, Z. Weng, Y. Zhao, J. He, Q. Wu, C. Ruan, Y. He

    Journal of Translational Medicine. 2017, 15, 214

  50. Cellular immune dysregulation in the pathogenesis of immune thrombocytopenia

    R. Wen, Y. Wang, Y. Hong, Z. Yang

    Blood Coagulation & Fibrinolysis. 2020, 31, 113-120

  51. Immune Thrombocytopenia: A Complex Autoimmune Disease

    Lee E-J, Bussel JB

    The Autoimmune Diseases, Elsevier. 2020, , 911-21

  52. Cytotoxic T lymphocytes: all roads lead to death

    M. Barry, R. Bleackley

    Nature Reviews Immunology. 2002, 2, 401-409

  53. Signal transduction by the TCR for antigen

    L. Kane, J. Lin, A. Weiss

    Current Opinion in Immunology. 2000, 12, 242-249

  54. Metabolism in T cell activation and differentiation

    E. Pearce

    Current Opinion in Immunology. 2010, 22, 314-320

  55. Perforin and granzymes: function, dysfunction and human pathology

    I. Voskoboinik, J. Whisstock, J. Trapani

    Nature Reviews Immunology. 2015, 15, 388-400

  56. Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, but Not Direct Granzyme B–Mediated Caspase Activation

    V. Sutton, J. Davis, M. Cancilla, R. Johnstone, A. Ruefli, K. Sedelies, K. Browne, J. Trapani

    Journal of Experimental Medicine. 2000, 192, 1403-1414

  57. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura

    F. Zhang, X. Chu, L. Wang, Y. Zhu, L. Li, D. Ma, J. Peng, M. Hou

    European Journal of Haematology. 2006, 76, 427-431

  58. Elevated Interleukin-21 Correlated to Th17 and Th1 Cells in Patients with Immune Thrombocytopenia

    X. Zhu, D. Ma, J. Zhang, J. Peng, X. Qu, C. Ji, M. Hou

    Journal of Clinical Immunology. 2010, 30, 253-259

  59. Investigation of platelet apoptosis in adult patients with chronic immune thrombocytopenia

    G. Deng, S. Yu, Q. Li, Y. He, W. Liang, L. Yu, D. Xu, T. Sun, R. Zhang, Q. Li

    Hematology. 2017, 22, 155-161

  60. Pediatric immune thrombocytopenia: apoptotic markers may help in predicting the disease course

    S. Levy-Mendelovich, S. Aviner, N. Sharon, H. Miskin, J. Yacobovich, G. Kenet, H. Hauschner, N. Rosenberg

    Pediatric Research. 2021, 90, 93-98

  61. Regulation of human helper T cell subset differentiation by cytokines

    N. Schmitt, H. Ueno

    Current Opinion in Immunology. 2015, 34, 130-136

  62. CD4+T Cells: Differentiation and Functions

    R. Luckheeram, R. Zhou, A. Verma, B. Xia

    Clinical and Developmental Immunology. 2012, 2012, 1-12

  63. A Three-cell Model for Activation of Naïve T Helper Cells

    A. Corthay

    Scandinavian Journal of Immunology. 2006, 64, 93-96

  64. TH1 and TH2 cells: a historical perspective

    F. Liew

    Nature Reviews Immunology. 2002, 2, 55-60

  65. IL-17 and Th17 Cells

    T. Korn, E. Bettelli, M. Oukka, V. Kuchroo

    Annual Review of Immunology. 2009, 27, 485-517

  66. IL-22 Produced by T helper Cell 22 as a New player in the Pathogenesis of Immune Thrombocytopenia

    G. Azizi, R. Yazdani, K. Hamid, A. Razavi, A. Mirshafiey

    Endocrine, Metabolic & Immune Disorders-Drug Targets. 2015, 15, 242-250

  67. Importance of Th22 Cell Disequilibrium in Immune Thrombocytopenic Purpura

    F. Zhan, J. Li, M. Fang, J. Ding, Q. Wang

    Medical Science Monitor. , 24, 8767-8772

  68. Effects of High-Dose Dexamethasone on Regulating Interleukin-22 Production and Correcting Th1 and Th22 Polarization in Immune Thrombocytopenia

    J. Cao, C. Chen, L. Li, L. Zeng, Z. Li, Z. Yan, W. Chen, H. Cheng, W. Sang, K. Xu

    Journal of Clinical Immunology. 2012, 32, 523-529

  69. The Th1/Th2 balance in autoimmunity

    B. Charlton, K. Lafferty

    Current Opinion in Immunology. 1995, 7, 793-798

  70. Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia

    Y. Hu, H. Li, L. Zhang, B. Shan, X. Xu, H. Li, X. Liu, S. Xu, S. Yu, D. Ma, J. Peng, M. Hou

    Human Immunology. 2012, 73, 629-635

  71. The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia

    A. Rocha, C. Souza, G. Rocha, F. de Melo, N. Clementino, M. Marino, A. Bozzi, M. Silva, O. Martins Filho, D. Queiroz

    Haematologica. 2011, 96, 1560-1564

  72. The role of different subsets of T regulatory cells in controlling autoimmunity

    M. Roncarolo, M. Levings

    Current Opinion in Immunology. 2000, 12, 676-683

  73. FOXP3+ regulatory T cells in the human immune system

    S. Sakaguchi, M. Miyara, C. Costantino, D. Hafler

    Nature Reviews Immunology. 2010, 10, 490-500

  74. Regulatory T cell CD4 ‏&CD25‏ expression and chemokine C-X-C ligand 13 level before and after corticosteroid therapy in pediatric ITP patients

    H. Ahmed, E. Fahmy, E. Nagiub Abdelsalam

    Pediatric Hematology Oncology Journal. 2019, 4, 39-43

  75. Mouse Models for Immune‐Mediated Platelet Destruction or Immune Thrombocytopenia (ITP)

    A. Neschadim, D. Branch

    Current Protocols in Immunology. 2016, 113,

  76. Acute Systemic Reaction and Lung Alterations Induced by an Antiplatelet Integrin gpIIb/IIIa Antibody in Mice

    B. Nieswandt, B. Echtenacher, F. Wachs, J. Schröder, J. Gessner, R. Schmidt, G. Grau, D. Männel

    Blood. 1999, 94, 684-693

  77. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbα antibodies

    M. Webster, E. Sayeh, M. Crow, P. Chen, B. Nieswandt, J. Freedman, H. Ni

    Blood. 2006, 108, 943-946

  78. Pharmacokinetic/Pharmacodynamic Modeling of IVIG Effects in a Murine Model of Immune Thrombocytopenia

    R. Deng, J. Balthasar

    Journal of Pharmaceutical Sciences. 2007, 96, 1625-1637

  79. A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell–mediated responses that are differentially sensitive to therapy

    L. Chow, R. Aslam, E. Speck, M. Kim, N. Cridland, M. Webster, P. Chen, K. Sahib, H. Ni, A. Lazarus, M. Garvey, J. Freedman, J. Semple

    Blood. 2010, 115, 1247-1253

  80. CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia

    L. Ma, E. Simpson, J. Li, M. Xuan, M. Xu, L. Baker, Y. Shi, I. Yougbaré, X. Wang, G. Zhu, P. Chen, G. Prud’homme, A. Lazarus, J. Freedman, H. Ni

    Blood. 2015, 126, 247-256

  81. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25)

    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M

    J Immunol . 1995, 155, 1151

  82. Critical role of CD4+CD25+ regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia

    T. Nishimoto, T. Satoh, T. Takeuchi, Y. Ikeda, M. Kuwana

    Experimental Hematology. 2012, 40, 279-289

  83. Induction of immune tolerance to platelet antigen by short-term thrombopoietin treatment in a mouse model of immune thrombocytopenia

    T. Nishimoto, M. Numajiri, H. Nakazaki, Y. Okazaki, M. Kuwana

    International Journal of Hematology. 2014, 100, 341-344

  84. Of Mice and Not Men: Differences between Mouse and Human Immunology

    J. Mestas, C. Hughes

    The Journal of Immunology. 2004, 172, 2731-2738

  85. Mathematical Techniques for Understanding Platelet Regulation and the Development of New Pharmacological Approaches

    Dunster JL, Panteleev MA, Gibbins JM, Sveshnikova AN

    Platelets and Megakaryocytes. 2018, 1812, 255-79

  86. Systems approaches meet biology and physiology: why do we need yet another journal?

    M. Panteleev

    System Biology and Physiology Reports. 2021, 1, 1-2

  87. Modeling and Simulation Support Eltrombopag Dosing in Pediatric Patients With Immune Thrombocytopenia

    M. Wire, X. Li, J. Zhang, W. Sallas, V. Aslanis, T. Ouatas

    Clinical Pharmacology & Therapeutics. 2018, 104, 1199-1207

  88. Heterogeneity of Integrin αIIbβ3 Function in Pediatric Immune Thrombocytopenia Revealed by Continuous Flow Cytometry Analysis

    A. Martyanov, D. Morozova, M. Sorokina, A. Filkova, D. Fedorova, S. Uzueva, E. Suntsova, G. Novichkova, P. Zharkov, M. Panteleev, A. Sveshnikova

    International Journal of Molecular Sciences. 2020, 21, 3035

  89. A strong correlation exists between platelet consumption and platelet hyperactivation in COVID-19 patients. Pilot study of the patient cohort from CCH RAS Hospital (Troitsk).

    M. Stepanyan, A. Martyanov, O. An, A. Boldova, S. Roumiantsev, A. Rumyantsev, M. Panteleev, F. Ataullakhanov, A. Sveshnikova

    Systems Biology and Physiology Reports. 2021, 1, 1-10